Oral supplementation of clay to dairy cattle has been reported to reduce toxicity of aflatoxin (AF) in contaminated feed. The objective of this study was to determine the effects of 3 concentrations of dietary clay supplementation in response to an AF challenge. Ten multiparous rumen-cannulated Holstein cows [body weight (mean ± SD) = 669 ± 20 kg and 146 ± 69 d in milk], were assigned to 1 of 5 treatments in a randomized replicated 5 × 5 Latin square design balanced to measure carryover effects. Periods (21 d) were divided in an adaptation phase (d 1 to 14) and a measurement phase (d 15 to 21). From d 15 to 17, cows received an AF challenge. The challenge consisted of 100 μg of aflatoxin B (AFB)/kg of dietary dry matter intake (DMI). The material was fitted into 10-mL gelatin capsules and administered into the rumen through a rumen-cannula based on the average DMI obtained on d 12 to 14. Treatments were no clay plus an AF challenge (POS); 3 different concentrations of clay (0.5, 1, or 2% of dietary DMI) plus an AF challenge; and a control consisting of no clay and no AF challenge (C). Statistical analysis was performed using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC). Two contrasts, CONT1 (POS vs. C) and CONT2 (POS vs. the average of 0.5, 1, and 2% clay), were compared along with the linear and quadratic treatment effects (POS, 0.5%, 1%, 2%). Cows supplemented with clay had lower AF excretion in milk as aflatoxin M (AFM; 0.5% = 20.83 μg/d, 1% = 22.82 μg/d, and 2% = 16.51 μg/d) and AF transfer from rumen fluid to milk (AFM 0.5% = 1.01%, 1% = 0.98%, and 2% = 0.74%) compared with cows in POS (AFM = 27.81 μg/d and AF transfer = 1.37%, CONT2). Similarly, concentrations of AFM in milk (0.5% = 0.35 μg/kg, 1% = 0.30 μg/kg, 2% = 0.25 μg/kg), AFB in feces (0.5% = 1.79 μg/g, 1% = 1.52 μg/kg, 2% = 1.48 μg/kg), and AFB in rumen fluid (0.5% = 0.05 μg/kg, 1% = 0.02 μg/kg, 2% = 0.02 μg/kg) were reduced in cows fed clay compared with POS (0.43 μg/kg, 2.78 μg/kg, and 0.10 μg/kg, respectively, CONT2). Cows supplemented with clay tended to have lower 3.5% fat-corrected milk [0.5% = 38.2 kg, 1% = 39.3 kg, 2% = 38.4 kg, standard error of the mean (SEM) = 1.8] than cows in POS (41.3 kg; SEM = 1.8; CONT2). Plasma superoxide dismutase (SOD) concentration tended to be lower for cows fed clay in the diet (0.5% = 2.16 U/mL, 1% = 1.90 U/mL, 2% = 2.3 U/mL; SEM = 0.3) than for cows in POS (2.72 U/mL; CONT2). Additionally, when cows were exposed to AF without clay in the diet, plasma concentrations of aspartate aminotransferase (AST) decreased from 84.23 (C) to 79.17 (POS) and glutamate dehydrogenase (GLDH) decreased from 91.02 (C) to 75.81 (POS). In conclusion, oral supplementation of clay reduced the transfer of AF from the rumen to milk and feces.
Oral supplementation of clay has been reported to function as buffer in dairy cows. However, its effects on rumen, blood, and fecal pH have varied among studies. Our objective was to determine the effects of 3 concentrations of dietary clay supplementation after a grain challenge. Ten multiparous rumen-cannulated Holstein cows [body weight (mean ± standard deviation)=648±12kg] with 142±130 (60 to 502) days in milk were assigned to 1 of 5 treatments in a replicated 5×5 Latin square design balanced to measure carryover effects. Periods (21d) were divided into an adaptation phase (d 1 to 18, with regular total mixed ration fed ad libitum) and a measurement phase (d 19 to 21). Feed was restricted on d 18 to 75% of the average of the total mixed ration fed from d 15 to 17 (dry matter basis), and on d 19 cows received a grain challenge. The challenge consisted of 20% finely ground wheat administered into the rumen via a rumen cannula, based on the average dry matter intake obtained on d 15 to 17. Treatments were POS (no clay plus a grain challenge), 3different concentrations of clay (0.5, 1, or 2% of dietary dry matter intake), and control (C; no clay and no grain challenge). Statistical analysis was performed using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC). Contrasts 1 (POS vs. C) and 2 (POS vs. the average of 0.5, 1, or 2%) were compared, along with linear and quadratic treatment effects. Rumen, fecal, and blood pH, along with blood metabolites, were measured at 0, 4, 8, 12, 16, 20, 24, 36, and 48h relative to the grain challenge. Cows fed POS had lower rumen pH [(mean ± standard error) 6.03±0.06] than cows fed C (6.20±0.06). Cow fed POS had lower fecal pH (6.14±0.04) than cows fed C (6.38±0.04). We observed a linear treatment effect for rumen pH and fecal pH. Fecal pH (6.22±0.04) was higher for cows fed clay (contrast 2) then for cows fed POS (6.14±0.04). We also observed a treatment difference (contrast 2) for negative incremental area under the curve, pH below 5.6 × h/d, (0.5% clay=7.93±0.83, 1% clay=8.56±0.83, and 2% clay=7.79±0.83) compared with POS (11.0±0.83). Cows fed clay tended to have higher milk yield (0.5% clay=28.8±3.4kg, 1% clay=30.2±3.4kg, and 2% clay=29.1±3.4kg, contrast 2), and had higher 3.5% fat-corrected milk (0.5% clay=29.9±3.5kg, 1% clay=34.1±3.5kg, and 2% clay=33.1±3.4kg), and higher energy-corrected milk (0.5% clay=29.1±3.3kg, 1% clay=32.8±3.4kg, and 2% clay=31.6±3.3kg) than cows fed POS (27.7±3.4kg, 28.0±3.4kg, 27.7±3.3kg, respectively). In conclusion, cows fed clay had higher rumen pH, energy-corrected milk, fat-corrected milk, and a trend for milk yield than cows fed POS.
Three experiments were conducted to determine the effect of increasing concentrations of a smectite clay on toxin binding capacity, ruminal fermentation, diet digestibility, and growth of feedlot cattle. In Exp. 1, 72 Angus × Simmental steers were blocked by BW (395 ± 9.9 kg) and randomly allotted to 3 treatments (4 pens/treatment and 6 steers/pen) to determine the effects of increasing amounts of clay (0, 1, or 2%) on performance. The clay was top-dressed on an 80% concentrate diet at a rate of 0, 113, or 226 g/steer daily to achieve the 0, 1, and 2% treatments, respectively. Steers were slaughtered at a target BW of 606 kg. In Exp. 2, 6 steers (596 ± 22.2 kg initial BW) were randomly allotted to the same 3 treatments in a replicated 3 × 3 Latin square design (21-d periods) to determine the effects of increasing amounts of clay on ruminal pH, VFA, and nutrient digestibility. In Exp. 3, 150 mg of clay was incubated in 10 mL of rumen fluid with 3 incremental concentrations (6 replicates per concentration) of aflatoxin B (AFB) or ergotamine tartate (ET) to determine binding capacity. During the first 33-d period, there was a quadratic effect of clay on ADG ( < 0.01) and G:F ( < 0.01), increasing from 0 to 1% clay and then decreasing from 1 to 2% clay. However, during the second 30-d period, clay linearly decreased ADG and G:F ( ≤ 0.03) and overall ADG, DMI, and G:F were not impacted ( ≥ 0.46). Clay linearly decreased marbling score ( = 0.05). Hepatic enzyme activity did not differ among treatments on d 0 or at slaughter ( ≥ 0.15). Clay linearly decreased ruminal lactate and propionate, linearly increased formate and the acetate:propionate ratio ( ≤ 0.04), and tended ( = 0.07) to linearly increase butyrate. Clay tended to linearly increase ( = 0.06) OM and CP apparent digestibility. Ruminal pH, urine pH, and other digestibility measures did not differ among treatments ( ≥ 0.15). Clay was able to effectively bind AFB and ET at concentrations above the normal physiological range (52 and 520 μg/mL), but proportional adsorption was decreased to 35.5 and 91.1% at 5,200 μg/mL ( < 0.01) for AFB and ET, respectively. In conclusion, clay effectively binds ruminal toxins, decreases ruminal lactate, and improves performance only during adaptation to a high-concentrate feedlot diet.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.